Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT05886517
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- AUSL Romagna Rimini
- Registry
-
NCT05886517
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT05886517. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-01 (actual); primary completion 2026-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
- Condition
- Aortic Stenosis
- Intervention (Device)
- Transfemoral transcatheter aortic valve implementation
- Lead sponsor
- AUSL Romagna Rimini
Record details
- Record id
cardio:ct-nct05886517- Content hash
a8d1822f745c9540bcd4f4bd87b1908e6f697260898d1db5e67c78a7ae2d16fb